Cabral Ramiro Martin 4
4 · Elanco Animal Health Inc · Filed Mar 3, 2023
Insider Transaction Report
Form 4
Cabral Ramiro Martin
SEE REMARKS
Transactions
- Tax Payment
Common Stock
2023-03-01$11.26/sh−3,490$39,297→ 79,451 total - Award
Common Stock
2023-03-01+37,745→ 117,196 total - Tax Payment
Common Stock
2023-03-02$11.01/sh−1,270$13,983→ 115,041 total - Award
Employee Stock Option (right to buy)
2023-03-01+86,207→ 86,207 totalExercise: $11.26Exp: 2033-03-01→ Common Stock (86,207 underlying)
Footnotes (4)
- [F1]Represents shares tendered to the Company to cover the Reporting Person's tax liability upon vesting of restricted stock units previously awarded under the Amended and Restated 2018 Elanco Stock Plan.
- [F2]Grant of restricted stock units pursuant to the Amended and Restated 2018 Elanco Stock Plan on March 1, 2023, one-third vesting on March 1, 2024, one-third vesting on March 1, 2025, and the remaining vesting on March 1, 2026.
- [F3]Balance reflects 885 fewer shares due to an error in the number of shares previously reported as forfeited in a prior Form 4.
- [F4]Grant of stock options vesting as follows: one-third vesting on March 1, 2024, one-third vesting on March 1, 2025, and the remaining vesting on March 1, 2026.